Active Ingredient History
Levocetirizine is the active enantiomer of cetirizine. It is inverse agonist of H1 receptors. Levocetirizine hydrochloride was approved for treatment of Allergic Rhinitis and Chronic Idiopathic Urticaria. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Rhinitis, Allergic (approved 2007)
Rhinitis, Allergic, Perennial (approved 2007)
Rhinitis, Allergic, Seasonal (approved 2007)
Allergy and Immunology (Phase 4)
Angioedema (Phase 3)
Anti-Allergic Agents (Phase 4)
Asthma (Phase 3)
Chronic Urticaria (Phase 4)
Colorectal Neoplasms (Phase 2)
Cough (Phase 2)
Dermatitis (Phase 3)
Dermatitis, Atopic (Phase 4)
Diabetic Nephropathies (Phase 2)
Eczema (Phase 3)
Fasting (Phase 1)
Healthy Volunteers (Phase 4)
Hypersensitivity (Phase 4)
Pruritus (Phase 4)
Rhinitis (Phase 4)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 4)
Rhinitis, Vasomotor (Phase 3)
Urticaria ()
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue